T

TESARO, Inc.

97 employees

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
drug development and commercialization
biopharmaceuticals
Biopharma
oncology

Date founded

2010

Funding rounds raised

Total raised

$155M

from 9 investors over 9 rounds

T

TESARO, Inc. raised $155M on March 10, 2016

Investors: Kleiner Perkins, Johnson & Johnson, Future Fund and InterWest Partners

T

TESARO, Inc. raised undisclosed on January 1, 2012

Investors: Sofinnova Ventures, Russia technology fund

T

TESARO, Inc. raised $101M on June 21, 2011

Investors: Leerink Partners LLC, Research Division, Kleiner Perkins, InterWest Partners and Pappas Ventures

FAQ